Registration and Abstract Submission opens
Early Registration Discount ends
Deadline for abstract submission for consideration as oral presentation.
Deadline for Eris Olson mentorship award normination
Young Investigator Competition Awards (YICA) Deadline
The ISHR NAS has established a variety of awards and lectures designed to recognize the dedication and leadership of its members. To highlight the distinguished recipients and presenters, the NAS@ISHR2020 meeting will host virtual events on December 7th, 2020 (Part II) for Award Lectures and Award Ceremony.
NAS leadership and NAS awards will host the Young Investigator Competition Awards (YICA) at at NAS2020 online meeting (Part II). In keeping with the mission of the ISHR NAS to foster the next generation of cardiovascular scientists, these prestigious awards are intended to highlight and support outstanding young investigators who have distinguished themselves for their scientific skills and accomplishments. We invite applications from graduate and medical students, postdoctoral fellows, and junior faculty.
NAS2020 has received a pledge of $9,000 sponsorship for YICA. Three junior and three senior finalists will be invited for oral presentations at the NAS2020 YICA event, scheduled on Sunday, December 6th, 2020. Two winners will each receive award recognition as well as $2,000 cash. The runner ups will be rewarded with $500 each.
The deadline for submitting YICA applications is October 16, 2020.
After reviewing the eligibilities and requirements, a compiled PDF file should be submitted to email@example.com by October 16, 2020.
Finalists of the YICA will be announced by November 20, 2020
The inaugural Eric N. Olson Mentorship Award at ISHR NAS was established this year to recognize a faculty member with a clear dedication to mentorship and their support of trainees and young scientists. This award will be given to a faculty member chosen by the Olson Mentorship Award Committee (Drs. Tim McKinsey, Kunhua Song, Mike Czubryt, and Lorrie Kirshenbaum).
Nominations for this award will be accepted by a compiled PDF file, including a letter of nomination jointly drafted by 2 or more trainees of the nominee (less than 2 pages), together with a copy of the nominee's CV, as well as the NIH bio-sketches of the trainees.
Please submit your nominations package to firstname.lastname@example.org by October 16, 2020.
Winners will be announced November 20, 2020.
Background on Dr. Eric N. Olson
Eric Olson is the founding Chair of the Department of Molecular Biology at The University of Texas Southwestern Medical Center. He also founded the Center for Regenerative Science and Medicine at UT Southwestern, which is advancing new strategies for organ regeneration. In addition, Dr. Olson directs the Wellstone Clinical Research Center for Muscular Dystrophy Research at UT Southwestern. He holds the Robert A. Welch Distinguished Chair, the Pogue Chair Distinguished Chair in Cardiac Birth Defects and the Annie and Willie Nelson Professorship in Stem Cell Research.
Dr. Olson is a member of the U.S. National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. His work has been recognized by numerous awards, including the Basic Research Prize, the Research Achievement Award and the Eugene Markwald Mentorship Award from the American Heart Association. He is among the most highly cited scientists in the world, with his work having been cited over 100,000 times in the scientific literature.
Eric Olson has trained ~120 fellows and students, many of whom now have independent positions in academia or industry. He and his trainees have discovered many of the key genes and mechanisms responsible for development of the heart and other muscles unveiling the signaling pathways responsible for pathological cardiac growth and heart failure. Olson’s discoveries at the interface of developmental biology and medicine have illuminated the fundamental principles of organ formation and have provided new concepts in the quest for cardiovascular therapeutics. His most recent work has provided a new strategy for correction of Duchenne muscular dystrophy using CRISPR gene editing.
Eric Olson has co-founded multiple biotechnology companies to design new therapies for heart muscle disease. Most recently, he founded Exonics Therapeutics together with Cure Duchenne Ventures, which is advancing gene editing as a therapy for Duchenne muscular dystrophy. Exonics was recently acquired by Vertex Pharmaceuticals. In his spare time, he plays guitar and harmonica with The Transactivators, a rock band inspired by the Texas troubadour, Willie Nelson, who created the Professorship that supports his research.
The Litsa Kranias ECI Leadership Award was founded to recognize early career scientists demonstrating astounding leadership qualities.
Background on Dr. Litsa Kranias
Litsa Kranias, PhD, is working to better understand the complex network of proteins contributing to heart function. As a professor of Pharmacology and Systems Physiology, Director of Cardiovascular Biology and Co-Director of the Cardiovascular Center of Excellence, Kranias has dedicated her career to researching cardiac illness and mentoring the next generation of researchers.
Much of Kranias’ research has focused on phospholamban (PLN), a cardiac protein that helps regulate contraction of the heart. However, Kranias and her colleagues discovered that PLN does not act alone—a complex set of proteins, including HAX-1, the heat shock protein 20 (HSP20) and protein phosphatase 1, work together to regulate PLN activity and cardiac contractility.
Kranias embraces her role as teacher and mentor, not only in her lab and her classroom, but in many other opportunities as well. She’s the senior advisor of ECI of NAS@ISHR. Her role as a mentor is also reflected in her leadership role as a co-principal investigator of an NIH Training award. Kranias’ dedication hasn’t gone unnoticed—two years ago, she was awarded the University of Cincinnati Mentorship award.
“I think that a very important aspect of our career is training the next generation of scientists,” said Kranias. “This is probably the biggest legacy we leave behind. The research is important—it will move the field forward—but having scientists to continue that is even more important.”
NAS has been fortunate to receive donations to inaugurate and to support this award in 2020.
It is designed to recognize NAS member(s) of ISHR for his/her innovative contributions to advance cardiovascular biology and medicine. The donors of this NAS Award did not offer additional requirements. Award nominations have been processed by NAS Leadership.
NAS2020 Innovator Awardee will be presenting an award lecture at NAS2020 and receiving a cash prize of $3,000 as well as a plaque.
NAS2020 continues its fine tradition and honors the dedication of its members with the NAS2020 President's Award. Award nominations are made by NAS President in consultation with NAS Executive Committee. NAS President's Award winner will be presenting an award lecture at NAS2020, receiving a cash prize of $1,000 as well as a plaque.